An immune signature to predict the prognosis of <i>ATRX</i>-wildtype glioma patients and guide immune checkpoint blockade therapy

Wenpeng Cao; Ping Sun; Shipeng Luo; Zhirui Zeng; Chaolun Xiao; Wenfeng Yu; Shan Lei

doi:doi:10.18632/aging.205088

← Back

Research Paper Volume 15, Issue 19 pp 10453—10472

An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy

Figure 3. Landscape of the 162 overlapping DEGs. (A) A PPI network was constructed using the 162 overlapping DEGs, and isolated genes were removed. Genes in the PPI network were set as candidate hub genes. (B) Molecular Function analysis of candidate hub genes. (C) Biological Process analysis of candidate hub genes. (D) Cellular Component analysis of candidate hub genes. (E) KEGG analysis of candidate central genes.